Status:
COMPLETED
Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese Subjects
Lead Sponsor:
Chonbuk National University Hospital
Conditions:
Overweight; Hyperlipidemia
Eligibility:
All Genders
19-70 years
Phase:
PHASE2
PHASE3
Brief Summary
Barley, like oats, is a rich source of the soluble fibre β-glucan, which has been shown to significantly lower LDL-cholesterol (LDL-C). However, barley foods have been less widely studied.
Detailed Description
This study investigated whether the supplementation of barley β-glucan is reduce the visceral fat as well as the serum low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in mildly ...
Eligibility Criteria
Inclusion
- an age from 19 to 70 years,
- a BMI(Body Mass Index) \>23 kg/m\^2,
- an LDL-C(Low Density Lipoprotein-cholesterol) concentration between 110 and 250 mg/dL
Exclusion
- they had heart disease, liver or kidney disease, food allergies, daily exercise habits, a body weight increase or decrease \>10 kg in the previous 3 months, irregular lifestyle habits
- they took medication and functional foods known to affect lipid metabolism.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01402128
Start Date
June 1 2010
End Date
May 1 2011
Last Update
December 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea, 560-822